Laboratory Historical Income Statement
LH Stock | USD 207.97 4.90 2.41% |
Historical analysis of Laboratory income statement accounts such as Operating Income of 832.3 M, EBIT of 865.8 M or Ebitda of 1.1 B can show how well Laboratory of performed in making a profits. Evaluating Laboratory income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Laboratory's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Laboratory latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Laboratory is a good buy for the upcoming year.
Laboratory |
About Laboratory Income Statement Analysis
Laboratory Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Laboratory shareholders. The income statement also shows Laboratory investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Laboratory Income Statement Chart
Laboratory of Income Statement is one of the three primary financial statements used for reporting Laboratory's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Laboratory revenue and expense. Laboratory Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Laboratory's Other Operating Expenses is increasing as compared to previous years. The Laboratory's current Cost Of Revenue is estimated to increase to about 9.5 B, while Gross Profit is projected to decrease to under 1.9 B. Add Fundamental
Total Revenue
Total revenue comprises all receipts Laboratory generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Laboratory of minus its cost of goods sold. It is profit before Laboratory operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Operating Income
Operating Income is the amount of profit realized from Laboratory operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Laboratory of is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Laboratory's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's Other Operating Expenses is increasing as compared to previous years. The Laboratory's current Cost Of Revenue is estimated to increase to about 9.5 B, while Gross Profit is projected to decrease to under 1.9 B.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.6B | 4.4B | 3.1B | 1.9B | Total Revenue | 16.1B | 14.9B | 12.2B | 12.8B |
Laboratory income statement Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 240.7M | 207.4M | 212.1M | 180.3M | 199.6M | 209.6M | |
Total Revenue | 11.6B | 14.0B | 16.1B | 14.9B | 12.2B | 12.8B | |
Gross Profit | 3.3B | 5.0B | 5.6B | 4.4B | 3.1B | 1.9B | |
Operating Income | 1.3B | 2.4B | 3.3B | 1.8B | 1.1B | 832.3M | |
Ebit | 1.3B | 2.4B | 3.3B | 1.8B | 1.1B | 865.8M | |
Ebitda | 2.0B | 3.5B | 4.1B | 2.7B | 1.7B | 1.1B | |
Depreciation And Amortization | 638.4M | 1.1B | 857.2M | 969.3M | 580.9M | 609.9M | |
Other Operating Expenses | 10.2B | 11.0B | 12.8B | 12.7B | 11.0B | 11.6B | |
Cost Of Revenue | 8.3B | 9.0B | 10.5B | 10.5B | 9.0B | 9.5B | |
Total Operating Expenses | 1.9B | 2.0B | 2.3B | 2.3B | 2.0B | 1.1B | |
Income Before Tax | 1.1B | 2.2B | 3.1B | 1.6B | 568.9M | 748.7M | |
Total Other Income Expense Net | (225.3M) | (226.3M) | (132.9M) | (191.3M) | (554.8M) | (527.1M) | |
Net Income | 823.8M | 1.6B | 2.4B | 1.3B | 418M | 513.9M | |
Income Tax Expense | 280M | 662.1M | 747.1M | 302M | 188.5M | 233.9M | |
Selling General Administrative | 1.6B | 1.7B | 2.0B | 2.0B | 2.2B | 1.1B | |
Net Income Applicable To Common Shares | 823.8M | (900K) | 2.4B | 1.3B | 1.5B | 1.5B | |
Minority Interest | 20.1M | 20.7M | (2.2M) | (1.5M) | (1.2M) | (1.1M) | |
Net Income From Continuing Ops | 824.9M | (900K) | 2.4B | 1.3B | 861.4M | 880.6M | |
Tax Provision | 280M | 662.1M | 747.1M | 302M | 210M | 379.6M | |
Interest Income | 212.3M | 194.2M | 175.4M | 166M | 149.4M | 166.7M | |
Net Interest Income | (240.7M) | (207.4M) | (212.1M) | (180.3M) | (200.4M) | (210.4M) | |
Reconciled Depreciation | 577.2M | 624.7M | 745.1M | 633.9M | 658M | 679.5M |
Laboratory Investors Sentiment
The influence of Laboratory's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Laboratory. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Laboratory's public news can be used to forecast risks associated with an investment in Laboratory. The trend in average sentiment can be used to explain how an investor holding Laboratory can time the market purely based on public headlines and social activities around Laboratory of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Laboratory's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Laboratory's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Laboratory's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Laboratory.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Laboratory in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Laboratory's short interest history, or implied volatility extrapolated from Laboratory options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.46) | Dividend Share 2.88 | Earnings Share 4.33 | Revenue Per Share 139.628 | Quarterly Revenue Growth 0.035 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.